If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksD4T4.L Regulatory News (D4T4)

  • There is currently no data for D4T4

Director/PDMR Shareholding

29 Oct 2009 07:00

RNS Number : 5500B
IS Solutions PLC
29 October 2009
 



IS Solutions Plc

Director's holdings

IS Solutions Plc ("IS Solutions" or "the Company"announces that it has been notified of an acquisition of shares in the Company as follows. On 27 October 2009, Michael Tinling, a non-executive director of the Company, purchased 35,000 shares in IS Solutions at 20p per share.

Following this transaction, Michael Tinling now has a beneficial interest in 344,659 shares in IS Solutions, representing 1.39 per cent of the Company's issued share capital.

 

Enquiries:

John Lythall, Managing Director

Fiona Tooley/Keith Gabriel

IS Solutions Plc

Citigate Dewe Rogerson Ltd

Tel: +44 (0) 1932 893333

Tel: +44 (0)121 362 4035

www.issolutions.co.uk

Mobile: +44 (0) 7785 703523

Charles Cunningham

FinnCap

Tel: +44 (0) 207 600 1658

Ticker: AIM: ISL

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSCKFKNOBDDPKB
Date   Source Headline
23rd Feb 20227:00 amRNSD4t4 to present at Counter Fraud 2022 Conference
22nd Feb 20225:47 pmRNSTransaction in Own Shares and TVR
18th Feb 20225:13 pmRNSTransaction in Own Shares and TVR
17th Feb 20228:36 amRNSExercise of Options and Transaction in Own Shares
15th Feb 20227:00 amRNSD4t4 expands partnership with Quantexa
11th Feb 20226:00 pmRNSTransaction in Own Shares and TVR
11th Feb 20227:00 amRNSD4t4 recognised in Cybersecurity Excellence Awards
9th Feb 20225:33 pmRNSTransaction in Own Shares and TVR
31st Jan 20224:43 pmRNSHolding(s) in Company
31st Jan 20222:46 pmRNSDirector/PDMR Shareholding
31st Jan 202210:33 amRNSHolding(s) in Company
28th Jan 20225:36 pmRNSTransaction in Own Shares and TVR
27th Jan 20225:04 pmRNSTransaction in Own Shares and TVR
26th Jan 20227:00 amRNSD4t4 strengthens US team with senior appointments
24th Jan 20225:52 pmRNSTransaction in Own Shares and TVR
10th Jan 20226:23 pmRNSTransaction in Own Shares and TVR
7th Jan 20222:48 pmRNSHolding(s) in Company
22nd Dec 20217:00 amRNSContract Wins
20th Dec 20215:04 pmRNSTransaction in Own Shares and TVR
14th Dec 20216:28 pmRNSTransaction in Own Shares and TVR
13th Dec 20216:18 pmRNSTransaction in Own Shares and TVR
13th Dec 20219:40 amRNSChange of auditor
6th Dec 202110:55 amRNSShare Buyback Programme
3rd Dec 202110:48 amRNSDirector/PDMR Shareholding
1st Dec 20217:00 amRNSHalf-year Results
30th Nov 20217:00 amRNSRelease of Celebrus Customer Data Platform update
16th Nov 20217:00 amRNSUpdates to Celebrus Fraud Data Platform
2nd Nov 202111:04 amRNSHolding(s) in Company
1st Nov 20211:50 pmRNSGrant of Awards under Long Term Incentive Plan
28th Oct 20211:30 pmRNSGrant of Awards under Long Term Incentive Plan
19th Oct 20215:11 pmRNSDirector/PDMR Shareholding
19th Oct 20217:00 amRNSTrading Update, CEO succession & Notice of Results
5th Oct 20217:00 amRNSExercise of options, transaction in own shares
1st Sep 20212:11 pmRNSBoard appointment
27th Aug 20217:00 amRNSBoard appointment
26th Aug 20219:14 amRNSResult of AGM
26th Aug 20217:00 amRNSAGM Statement
2nd Aug 20217:00 amRNSAppointment of CFO
2nd Aug 20217:00 amRNSAcquisition of Prickly Cactus
28th Jul 20211:25 pmRNSNotice of AGM, Dividend Timetable & Annual Report
28th Jul 202112:12 pmRNSNotice of AGM, Dividend Timetable & Annual Report
1st Jul 202111:25 amRNSDirector/PDMR Shareholding
30th Jun 202110:42 amRNSDirector/PDMR Shareholding
29th Jun 20217:00 amRNSPreliminary results and board changes
15th Jun 20217:00 amRNSLaunch of Celebrus Fraud Data Platform
25th May 20212:00 pmRNSLaunch of Celebrus Version 9.4
19th Apr 20212:05 pmRNSSecond Price Monitoring Extn
19th Apr 20212:00 pmRNSPrice Monitoring Extension
19th Apr 202111:05 amRNSSecond Price Monitoring Extn
19th Apr 202111:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.